Cell and gene therapies demand complex logistics beyond traditional trials, requiring precise tracking of samples, manufacturing, and delivery unique to each patient. IQVIA IRT enables this with configurable, flexible systems that manage identifiers, shipments, expiries, and treatment lifecycles. Their consultative approach tailors builds to protocol needs, avoiding data errors and supporting sponsors of all sizes. A mini case study showed IRT’s adaptability in tracking thawed treatments, expiry dates, and real-time shipment statuses. With expertise from over 1,500 trials, IQVIA provides quality, innovation, and customizable technology to advance cell and gene therapy research.

Join for free to read